Adhera Therapeutics Inc (ATRX)
0.006
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Adhera Therapeutics Shareholders Equity (Quarterly): -26.32M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -26.32M |
June 30, 2023 | -22.79M |
March 31, 2023 | -23.09M |
December 31, 2022 | -22.19M |
September 30, 2022 | -21.81M |
June 30, 2022 | -20.00M |
March 31, 2022 | -25.50M |
December 31, 2021 | -25.11M |
September 30, 2021 | -20.24M |
June 30, 2021 | -16.34M |
March 31, 2021 | -15.50M |
December 31, 2020 | -14.77M |
September 30, 2020 | -14.03M |
June 30, 2020 | -13.10M |
March 31, 2020 | -11.83M |
December 31, 2019 | -9.887M |
September 30, 2019 | -5.384M |
June 30, 2019 | -2.511M |
March 31, 2019 | 0.3823M |
December 31, 2018 | 2.927M |
September 30, 2018 | 6.113M |
June 30, 2018 | 12.13M |
March 31, 2018 | -0.794M |
December 31, 2017 | 0.4482M |
September 30, 2017 | 1.631M |
Date | Value |
---|---|
June 30, 2017 | 2.474M |
March 31, 2017 | 3.419M |
December 31, 2016 | 3.219M |
September 30, 2016 | 1.403M |
June 30, 2016 | 1.075M |
March 31, 2016 | 1.486M |
December 31, 2015 | 0.263M |
September 30, 2015 | -0.40M |
June 30, 2015 | -2.495M |
March 31, 2015 | -3.651M |
December 31, 2014 | -4.371M |
September 30, 2014 | -10.19M |
June 30, 2014 | -3.328M |
March 31, 2014 | -7.297M |
December 31, 2013 | -7.064M |
September 30, 2013 | -5.142M |
June 30, 2013 | -4.202M |
March 31, 2013 | -4.223M |
December 31, 2012 | -5.628M |
September 30, 2012 | -2.35M |
June 30, 2012 | -1.851M |
March 31, 2012 | -3.337M |
December 31, 2011 | 0.038M |
September 30, 2011 | 15.88M |
June 30, 2011 | 16.32M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-26.32M
Minimum
Sep 2023
-2.511M
Maximum
Jun 2019
-17.24M
Average
-18.17M
Median
Shareholders Equity (Quarterly) Benchmarks
AIM ImmunoTech Inc | 10.23M |
Perspective Therapeutics Inc | 229.89M |
Protalix BioTherapeutics Inc | 29.79M |
Electromed Inc | 42.54M |
Armata Pharmaceuticals Inc | -56.51M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.0441M |
Total Liabilities (Quarterly) | 26.36M |